Skip to main content

Table 2 Lipid plasma concentrations of HDL subclasses

From: Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses

 

Group

Subclasses

HDL 2b

HDL 2a

HDL 3a

HDL 3b

HDL 3c

TC (mg/dL)

Control

11.74 ± 1.11

5.71 ± 0.44

11.19 ± 0.80

6.16 ± 0.47

6.16 ± 0.42

CAD

9.27 ± 1.12

4.26 ± 0.25*

7.92 ± 0.64*

4.59 ± 0.35*

3.43 ± 0.24†

FC (mg/dL)

Control

3.53 ± 0.55

1.34 ± 0.19

2.64 ± 0.45

1.08 ± 0.18

1.13 ± 0.16

CAD

4.00 ± 0.34

1.60 ± 0.13

3.06 ± 0.27

1.46 ± 0.12

1.14 ± 0.11

EC (mg/dL)

Control

14.62 ± 1.84

7.33 ± 0.72

13.73 ± 1.53

8.66 ± 0.73

8.02 ± 0.57

CAD

8.26 ± 1.85

4.47 ± 0.43*

9.55 ± 1.01*

5.29 ± 0.59*

3.84 ± 0.33†

TG (mg/dL)

Control

8.56 ± 1.10

4.63 ± 0.56

8.40 ± 0.79

4.13 ± 0.46

4.37 ± 0.45

CAD

10.14 ± 0.97

4.20 ± 0.43

6.56 ± 0.43

2.97 ± 0.21*

1.66 ± 0.23†

PH (mg/dL)

Control

21.08 ± 1.07

9.52 ± 0.54

18.20 ± 1.12

10.11 ± 0.90

10.65 ± 1.52

CAD

25.55 ± 2.00

10.42 ± 0.76

16.58 ± 1.23

8.86 ± 0.66

7.18 ± 0.63

  1. TC total cholesterol; FC free cholesterol; EC esterified cholesterol; TG triglycerides; PH phospholipids
  2. Data are shown as mean ± SE. n = 15 by group. Student’s t test †p < 0.01, and *p < 0.05 vs. control group